COVID-19: So What’s New?

Katherine Yang, PharmD, MPH, FCSHP is a Health Sciences Clinical Professor of Pharmacy at the UCSF School of Pharmacy and an infectious diseases clinical pharmacist at the UCSF Medical Center in San Francisco, California. Dr. Yang specializes in the pharmacokinetic and pharmacodynamic optimization of antibiotic dosing for the treatment of multi-drug resistant gram-negative infections. Since the start of the pandemic, Dr. Yang has been heavily involved in the management of COVID-19 therapeutics. 

Sarah Parsons, PharmD, BCPPS, FPPA is a clinical pharmacy specialist in pediatric infectious diseases and the co-director of the antimicrobial stewardship program at the Children’s Hospital of The King’s Daughters. Dr. Parsons received her Doctor of Pharmacy Degree from Virginia Commonwealth School of Pharmacy. She completed a PGY1 with pediatric focus at HCA Health system in Richmond, Virginia. Dr. Parsons specializes in the treatment of multi-drug resistant gram negative infections, nontuberculous mycobacterium in cystic fibrosis, COVID/MIS-C, and vaccine preventable diseases in children. She is an active member of many pharmacy, pediatric, and infectious diseases professional organizations, including ASHP, the Pediatric Infectious Diseases Society, the Society of Infectious Diseases Pharmacists, the American College of Clinical Pharmacy, and is a 2025 fellow of the Pediatric Pharmacy Association.

Monica Mahoney, PharmD, BCPS, BCIDP, FCCP, FIDSA, FIDP, FMSHP is a clinical pharmacy specialist in the outpatient infectious diseases and outpatient parenteral antibiotic therapy (OPAT) clinics at Beth Israel Deaconess Medical Center in Boston, MA. Dr. Mahoney received her PharmD degree from MCPHS University in Boston, Massachusetts. She completed postgraduate year 1 residency and postgraduate year 2 infectious diseases residency at Tufts Medical Center in Boston, Massachusetts. She is an active member of many pharmacy and infectious diseases professional organizations, including ASHP, the Society of Infectious Diseases Pharmacists, the Infectious Diseases Society of America, and the Society for Healthcare Epidemiology of America. She is an associate editor at Open Forum Infectious Diseases (OFID), section editor at Contagion Live, and on the editorial board for Antimicrobial Stewardship & Hospital Epidemiology (ASHE).

Michael Ganio, PharmD, MS, BCSCP, FASHP joined the staff at ASHP as Director of Pharmacy Practice and Quality in January of 2018. As a member of the Center on Medication Safety and Quality team, his responsibilities span the practice of pharmacy and include drug shortages, pharmaceutical quality, sterile and non-sterile drug compounding practices, hazardous drug handling, and the ASHP Standardize 4 Safety initiative. Dr. Ganio earned his Pharm.D. from the Rutgers University Ernest Mario School of Pharmacy and his Master’s degree in Health-System Pharmacy Administration from The Ohio State University College of Pharmacy. He completed a PGY1 Pharmacy Practice residency at The Ohio State University Wexner Medical Center. Dr. Ganio is a Board Certified Pharmacotherapy Specialist (BCPS) and a Board Certified Sterile Compounding Pharmacist (BCSCP).

Relevant Financial Relationship Disclosures

The following persons in control of this activity’s content have relevant financial relationships:

• Monica V. Mahoney: BD Bioscience – Consultant, Speaker’s bureau; GSK – Consultant; Cidara – Consultant; Pfizer – Consultant

All other persons in control of content do not have any relevant financial relationships with an ineligible company. As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company. 

Resources

•  Office Hours Roundtable: Enhancing Care for Special Patient Populations in the Shadow of the COVID-19 Pandemic

More in this Series

• FLiRTing with COVID - Are We Out of the Woods Yet?